| Dr Timothy Edward Reineck, OD | |
|
903 Tiffin Ave, Findlay, OH 45840-5857 | |
| (419) 423-4000 | |
| (419) 423-2232 |
| Full Name | Dr Timothy Edward Reineck |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 42 Years |
| Location | 903 Tiffin Ave, Findlay, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679565022 | NPI | - | NPPES |
| 0490820 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 3630/T609 (Ohio) | Primary |
| 152WC0802X | Optometrist - Corneal And Contact Management | 3630/T609 (Ohio) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Susan Ross Od Professional Corp | 7618207036 | 57 |
News Archive
A new device that can rapidly concentrate and extract young cells from irrigation fluid used during orthopaedic surgery holds promise for improving the delivery of stem cell therapy in cases of non-healing fractures. UC Davis surgeons plan to launch a "proof-of-concept" clinical trial to test the safety and efficacy of the device in the coming months.
Hoarding friends on Facebook - or followers on Twitter - won't do much to stave off loneliness if those relationships lack any kind of strong connection, new research finds.
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.
UnitedHealth Group Inc. (UNH), the biggest U.S. health insurer, increased its 2012 earnings forecast after reporting that first-quarter profit beat analysts' estimates for higher enrollment and low medical costs. ... UnitedHealth's shares climbed, along with other health insurers, after Chief Executive Officer Stephen Hemsley said he expects only a "gradual" rise in health spending this year.
Emdat announces the launch of DaRT, or Discrete accurate Reportable Transcription, a solution that enables more efficient utilization of electronic medical records by seamlessly integrating with Emdat's online medical transcription platform.
› Verified 3 days ago
| Provider Name | Susan Ross Od Professional Corp |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1154980811 PECOS PAC ID: 7618207036 Enrollment ID: O20190927002244 |
News Archive
A new device that can rapidly concentrate and extract young cells from irrigation fluid used during orthopaedic surgery holds promise for improving the delivery of stem cell therapy in cases of non-healing fractures. UC Davis surgeons plan to launch a "proof-of-concept" clinical trial to test the safety and efficacy of the device in the coming months.
Hoarding friends on Facebook - or followers on Twitter - won't do much to stave off loneliness if those relationships lack any kind of strong connection, new research finds.
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.
UnitedHealth Group Inc. (UNH), the biggest U.S. health insurer, increased its 2012 earnings forecast after reporting that first-quarter profit beat analysts' estimates for higher enrollment and low medical costs. ... UnitedHealth's shares climbed, along with other health insurers, after Chief Executive Officer Stephen Hemsley said he expects only a "gradual" rise in health spending this year.
Emdat announces the launch of DaRT, or Discrete accurate Reportable Transcription, a solution that enables more efficient utilization of electronic medical records by seamlessly integrating with Emdat's online medical transcription platform.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Timothy Edward Reineck, OD 903 Tiffin Ave, Findlay, OH 45840-5857 Ph: (419) 423-4000 | Dr Timothy Edward Reineck, OD 903 Tiffin Ave, Findlay, OH 45840-5857 Ph: (419) 423-4000 |
News Archive
A new device that can rapidly concentrate and extract young cells from irrigation fluid used during orthopaedic surgery holds promise for improving the delivery of stem cell therapy in cases of non-healing fractures. UC Davis surgeons plan to launch a "proof-of-concept" clinical trial to test the safety and efficacy of the device in the coming months.
Hoarding friends on Facebook - or followers on Twitter - won't do much to stave off loneliness if those relationships lack any kind of strong connection, new research finds.
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.
UnitedHealth Group Inc. (UNH), the biggest U.S. health insurer, increased its 2012 earnings forecast after reporting that first-quarter profit beat analysts' estimates for higher enrollment and low medical costs. ... UnitedHealth's shares climbed, along with other health insurers, after Chief Executive Officer Stephen Hemsley said he expects only a "gradual" rise in health spending this year.
Emdat announces the launch of DaRT, or Discrete accurate Reportable Transcription, a solution that enables more efficient utilization of electronic medical records by seamlessly integrating with Emdat's online medical transcription platform.
› Verified 3 days ago
Sarah Wildermuth, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 334 S Main St, Findlay, OH 45840 Phone: 419-422-2015 | |
The Sight Center Of Northwest Ohio Optometrist Medicare: Not Enrolled in Medicare Practice Location: 15840 Medical Dr. South, Suite A, Findlay, OH 45840 Phone: 419-720-3937 | |
Horizon Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1318 N Main St, Findlay, OH 45840 Phone: 419-425-4378 Fax: 419-425-4377 | |
Dr. John Eric Vandemark, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1318 N Main St, Findlay, OH 45840 Phone: 419-452-4378 Fax: 419-425-4377 | |
Jeffrey David Dailey, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2500 Tiffin Ave, C/o Findlay Wal-mart Vision Center, Findlay, OH 45840 Phone: 419-425-2125 Fax: 419-425-3936 | |
Dr. Bruce Alan Vasiloff, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2500 Tiffin Ave, Findlay, OH 45840 Phone: 419-425-2125 Fax: 419-425-3936 | |
Richard J Herr, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 123 W Sandusky St, Findlay, OH 45840 Phone: 419-422-3472 Fax: 419-422-3786 |